Restylane Kysse Injectable Gel
FDA premarket approval P140029/S037 · decided 2021-04-14
Approval details
- PMA number
- P140029
- Supplement
- S037
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Restylane Kysse Injectable Gel
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Q-Med AB
- Date received
- 2021-03-15
- Decision date
- 2021-04-14
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Uppsala
- Statement
- Changes in the dialysis procedure for the manufacturing of Restylane Kysse to permit parallel dialysis of two batches of the same product at the same time.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.